|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sandhu V, Wedge DC, Bowitz Lothe IM,
Labori KJ, Dentro SC, Buanes T, Skrede ML, Dalsgaard AM, Munthe E,
Myklebost O, et al: The genomic landscape of pancreatic and
periampullary adenocarcinoma. Cancer Res. 76:5092–5102. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang MJ, Jang JY, Kwon W and Kim SW:
Clinical significance of defining borderline resectable pancreatic
cancer. Pancreatology. 18:139–145. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhosale P, Cox V, Faria S, Javadi S,
Viswanathan C, Koay E and Tamm E: Genetics of pancreatic cancer and
implications for therapy. Abdom Radiol (NY). 43:404–414. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Treves S, Feriotto G, Moccagatta L,
Gambari R and Zorzato F: Molecular cloning, expression, functional
characterization, chromosomal localization, and gene structure of
junctate, a novel integral calcium binding protein of
sarco(endo)plasmic reticulum membrane. J Biol Chem.
275:39555–39568. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou XL, Thorgeirsson SS and Popescu NC:
Restoration of DLC-1 gene expression induces apoptosis and inhibits
both cell growth and tumorigenicity in human hepatocellular
carcinoma cells. Oncogene. 23:1308–1313. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan BZ, Jefferson AM, Baldwin KT,
Thorgeirsson SS, Popescu NC and Reynolds SH: DLC-1 operates as a
tumor suppressor gene in human non-small cell lung carcinomas.
Oncogene. 23:1405–1411. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ng IO, Liang ZD, Cao L and Lee TK: DLC-1
is deleted in primary hepatocellular carcinoma and exerts
inhibitory effects on the proliferation of hepatoma cell lines with
deleted DLC-1. Cancer Res. 60:6581–6584. 2000.PubMed/NCBI
|
|
9
|
Basak P, Dillon R, Leslie H, Raouf A and
Mowat MR: The deleted in liver cancer 1 (Dlc1) tumor suppressor is
haploinsufficient for mammary gland development and epithelial cell
polarity. BMC Cancer. 15:6302015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ullmannova-Benson V, Guan M, Zhou X,
Tripathi V, Yang XY, Zimonjic DB and Popescu NC: DLC1 tumor
suppressor gene inhibits migration and invasion of multiple myeloma
cells through RhoA GTPase pathway. Leukemia. 23:383–390. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xue W, Krasnitz A, Lucito R, Sordella R,
Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers
S, et al: DLC1 is a chromosome 8p tumor suppressor whose loss
promotes hepatocellular carcinoma. Gene Dev. 22:1439–1444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lahoz A and Hall A: DLC1: A significant
GAP in the cancer genome. Gene Dev. 22:1724–1730. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wuestefeld T and Zender L: DLC1 and liver
cancer: The Akt connection. Gastroenterology. 139:1093–1096. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song LJ, Liu Q, Meng XR, Li ShL, Wang LX,
Fan QX and Xuan XY: DLC-1 is an independent prognostic marker and
potential therapeutic target in hepatocellular cancer. Diagn
Pathol. 11:192016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shih YP, Takada Y and Lo SH: Silencing of
DLC1 upregulates PAI-1 expression and reduces migration in normal
prostate cells. Mol Cancer Res. 10:34–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue YZ, Wu TL, Wu YM, Sheng YY, Wei ZQ, Lu
YF, Yu LH, Li JP and Li ZS: DLC-1 is a candidate biomarker
methylated and down-regulated in pancreatic ductal adenocarcinoma.
Tumor Biol. 34:2857–2861. 2013. View Article : Google Scholar
|
|
17
|
Popescu NC and Goodison S: Deleted in
liver cancer-1 (DLC1): An emerging metastasis suppressor gene. Mol
Diagn Ther. 18:293–302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qian X, Li G, Asmussen HK, Asnaghi L, Vass
WC, Braverman R, Yamada KM, Popescu NC, Papageorge AG and Lowy DR:
Oncogenic inhibition by a deleted in liver cancer gene requires
cooperation between tensin binding and rho-specific
GTPase-activating protein activities. Proc Natl Acad Sci USA.
104:9012–9017. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian X, Durkin ME, Wang D, Tripathi BK,
Olson L, Yang XY, Vass WC, Popescu NC and Lowy DR: Inactivation of
the Dlc1 gene cooperates with downregulation of p15INK4b and
p16Ink4a, leading to neoplastic transformation and poor prognosis
in human cancer. Cancer Res. 72:5900–5911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ko FC and Ping Yam JW: Regulation of
deleted in liver cancer 1 tumor suppressor by protein-protein
interactions and phosphorylation. Int J Cancer. 135:264–269. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ullmannova V and Popescu NC: Expression
profile of the tumor suppressor genes DLC-1 and DLC-2 in solid
tumors. Int J Oncol. 29:1127–1132. 2006.PubMed/NCBI
|
|
22
|
Dai ZS and Jin YL: Promoter methylation of
the DLC-1 gene and its inhibitory effect on human colon cancer.
Oncol Rep. 30:1511–1517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li GR, Du XL, Vass WC, Papageorge AG, Lowy
DR and Qian XL: Full activity of the deleted in liver cancer 1
(DLC1) tumor suppressor depends on an LD-like motif that binds
talin and focal adhesion kinase (FAK). Proc Natl Acad Sci USA.
108:17129–17134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Palombella S, Pirrone C, Cherubino M,
Valdatta L, Bernardini G and Gornati R: Identification of reference
genes for qPCR analysis during hASC long culture maintenance. PLoS
One. 12:e01709182017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Wang J, Liu H and Fu Z: Tumor
suppressor DLC-1 induces apoptosis and inhibits the growth and
invasion of colon cancer cells through the wnt/beta-catenin
signaling pathway. Oncol Rep. 31:2270–2278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boulter N, Suarez FG, Schibeci S,
Sunderland T, Tolhurst O, Hunter T, Hodge G, Handelsman D,
Simanainen U, Hendriks E and Duggan K: A simple, accurate and
universal method for quantification of PCR. BMC Biotechnol.
16:272016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Larionov A, Krause A and Miller W: A
standard curve based method for relative real time PCR data
processing. Bmc Bioinformatics. 21:622005. View Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou X, Xu X, Wang J, Lin J and Chen W:
Identifying miRNA/mRNA negative regulation pairs in colorectal
cancer. Sci Rep. 5:129952015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang P, Qiao Y, Wang C, Ma L and Su M:
Enhanced radiation therapy with internalized polyelectrolyte
modified nanoparticles. Nanoscale. 6:10095–10099. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakano T, Kanai Y, Amano Y, Yoshimoto T,
Matsubara D, Shibano T, Tamura T, Oguni S, Katashiba S, Ito T, et
al: Establishment of highly metastatic KRAS mutant lung cancer cell
sublines in long-term three-dimensional low attachment cultures.
PLoS One. 12:e01813422017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Neuhoff V, Stamm R, Pardowitz I, Arold N,
Ehrhardt W and Taube D: Essential problems in quantification of
proteins following colloidal staining with coomassie brilliant blue
dyes in polyacrylamide gels, and their solution. Electrophoresis.
11:101–117. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Esmaeelian B, Benkendorff K, Johnston MR
and Abbott CA: Purified brominated indole derivatives from
dicathais orbita induce apoptosis and cell cycle arrest in
colorectal cancer cell lines. Mar Drugs. 11:3802–3822. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Braun AC and Olayioye MA: Rho regulation:
DLC proteins in space and time. Cell Signal. 27:1643–1651. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yam JW, Ko FC, Chan CY, Jin DY and Ng IO:
Interaction of deleted in liver cancer 1 with tensin2 in caveolae
and implications in tumor suppression. Cancer Res. 66:8367–8372.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim TY, Jackson S, Xiong Y, Whitsett TG,
Lobello JR, Weiss GJ, Tran NL, Bang YJ and Der CJ:
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating
protein tumor suppressor promotes non-small cell lung cancer cell
growth. Proc Natl Acad Sci USA. 110:16868–16873. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wong CC, Wong CM, Ko FC, Chan LK, Ching
YP, Yam JW and Ng IO: Deleted in liver cancer 1 (DLC1) negatively
regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma. PLoS
One. 23:e27792008. View Article : Google Scholar
|
|
40
|
Cao X, Kaneko T, Li JS, Liu AD, Voss C and
Li SS: A phosphorylation switch controls the spatiotemporal
activation of rho GTPases in directional cell migration. Nat
Commun. 6:77212015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Du X, Qian X, Papageorge A, Schetter AJ,
Vass WC, Liu X, Braverman R, Robles AI and Lowy DR: Functional
interaction of tumor suppressor DLC1 and caveolin-1 in cancer
cells. Cancer Res. 72:4405–4416. 2012. View Article : Google Scholar : PubMed/NCBI
|
